> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Covid-19 Guidances
- URL: https://www.fdaweb.com/comments-sought-on-covid-19-guidances/
- Published: 2020-10-16T12:00:00.000Z
- Updated: 2026-09-14T16:32:57.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147890

*Federal Register* notice: FDA has made available three guidance documents related to the Covid–19 public health emergency. The guidances have been implemented without prior comment, but they remain subject to comment under the agency’s good guidance practices. They are: 

- *Manufacturing, Supply Chain, and Drug and Biological Product Inspections During Covid–19 Public Health Emergency Questions and Answers* (issued 8/2020)
- Resuming Normal Drug and Biologics Manufacturing Operations During the Covid–19 Public Health Emergency (issued 9/2020)
- *FDA Guidance on Conduct of Clinical Trials of Medical Products during Covid–19 Public Health Emergency* (issued 3/2020 and updated 9/2020)

To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-10-16/pdf/2020-22968.pdf?ref=fdaweb.com).